Baxter’s Foray Into CAR-T Cell Therapy With a Deal Worth US$ 1.7 B |
Abstract
pdf
html
|
Taskin Ahmed & Rohit Khera |
|
AbbVie adds Boehringer Ingelheim’s BI 655066 to its Autoimmune Portfolio |
Abstract
pdf
html
|
Natasha Berry |
|
Exelixis Partners its Oncology Drug Cabozantinib with Ipsen for US$200 M Upfront |
Abstract
pdf
html
|
Heather Cartwright & Jasmine Kalsi |
|
Acorda Boosts Parkinson’s Disease Franchise with US$363 M Acquisition of Biotie |
Abstract
pdf
html
|
Heather Cartwright & Sayani Datta |
|
IMS PharmaDeals Review of 2015 |
Abstract
pdf
|
Heather Cartwright & Taskin Ahmed |
|